Effect of Hemp-CBD on Patients With CIPN

ABSTRACT: The purpose of this study is to assess the effect of a hemp-based cannabidiol (CBD) product, Ananda Hemp Spectrum Gelcaps, on the severity and duration of chemotherapy-induced neuropathy (CIPN) among non-metastatic breast, uterine, pancreatic, and colorectal cancer, and all stages of ovarian cancer in patients who received neoadjuvant or adjuvant therapy that included neurotoxic chemotherapeutic agents.

DISEASE(S): Ovarian Cancer,Chemotherapy-induced Peripheral Neuropathy,Uterine Neoplasms,Peripheral Nervous System Diseases,Carcinoma, Ovarian Epithelial,Uterine Cancer,Colorectal Neoplasms,Pancreatic Cancer,Ovarian Neoplasms,Breast Cancer,Colorectal Cancer Stage Ii,Colorectal Cancer Stage Iii

PROVIDER: 2340003 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR